Orion Sponsor Holdings, LLC - Jun 25, 2021 Form 4 Insider Report for Orion Biotech Opportunities Corp. (ORIA)

Role
10%+ Owner
Signature
/s/ Marcello Liguori By: Marcello Liguori Title: Vice President
Stock symbol
ORIA
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/30/2021, 07:24 PM
Previous filing
May 12, 2021
Next filing
May 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIA Class B Ordinary Shares Other -750K -13.32% 4.88M Jun 25, 2021 Class A Ordinary Shares 750K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-253548) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001 per share (the "Class B ordinary shares"), will automatically convert into Class A ordinary shares, par value $0.0001 per share at the time of the issuer's initial business combination on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
F2 This Form 4 reflects the automatic surrender to the issuer of 750,000 Class B ordinary shares, which were automatically surrendered to the issuer for no consideration by the reporting person pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriters of the issuer's initial public offering to purchase additional units.
F3 This Form 4 is being filed by Orion Sponsor Holdings, LLC (the "Sponsor"). The Sponsor is managed by a board of managers comprised of James Huang, John Phelan and Robert Platek, who control the Sponsor. Accordingly, Messrs. Huang, Phelan and Platek have voting and investment discretion with respect to the securities held by the Sponsor, and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Huang, Phelan and Platek disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.